ArticleCancer medicine2021

Knockout of vasohibin-2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer.

Takahiro Koyanagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.